ArticleBMC family practice2015
Generalized anxiety disorder in primary care: mental health services use and treatment adequacy.
Article in BMC family practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Systematic review and network meta-analysis of agomelatine for the treatment of generalized anxiety disorder in adult patients.International clinical psychopharmacology · 2025Pooled it
- Two decades of digital interventions for anxiety disorders: a systematic review and meta-analysis of treatment effectiveness.Psychological medicine · 2023Pooled it
- A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine.Frontiers in psychiatry · 2020Pooled it
- A review of neuroimaging studies in generalized anxiety disorder: "So where do we stand?"Journal of neural transmission (Vienna, Austria : 1996) · 2019Pooled it
- Basil (Ocimum basilicum) to Alleviate Anxiety in Patients With Major Depressive Disorder: A Randomized Placebo-Controlled Clinical Trial.Brain and behavior · 2025Trial
- Effectiveness of a web-based decision aid for patients with Generalised Anxiety Disorder in Spain: a randomised controlled trial.BMJ health & care informatics · 2025Trial
- Web-based interpretation bias training to reduce anxiety: A sequential, multiple-assignment randomized trial.Journal of consulting and clinical psychology · 2024Trial
- Cost-Effectiveness of Group Transdiagnostic Cognitive Behavioural Therapy for Anxiety Disorders in Primary Care Settings: Economic Evaluation From the Healthcare System Perspective Over a 1-Year Time Horizon.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2024Trial
- Trial
- Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity.International clinical psychopharmacology · 2019Trial
- Challenges to treatment preparedness among lung cancer patients from a healthcare provider perspective: a mixed-method study.npj health systems · 2026Article
- Resting-State Cortical Network and Subcortical Hyperconnectivity in Youth With Generalized Anxiety Disorder in the ABCD Study.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2026Article
- Profiles of physician follow-up care, correlates and outcomes among patients affected by an incident mental disorder.BMC primary care · 2025Observational
- Generalized anxiety disorder screening scores are associated with greater treatment need among Veterans with depression.Journal of psychiatric research · 2024Article
- A Machine Learning Approach for Continuous Mining of Nonidentifiable Smartphone Data to Create a Novel Digital Biomarker Detecting Generalized Anxiety Disorder: Prospective Cohort Study.JMIR medical informatics · 2022Article
- Decision aids linked to the recommendations in clinical practice guidelines: results of the acceptability of a decision aid for patients with generalized anxiety disorder.BMC medical informatics and decision making · 2022Article
- Anxiety symptoms in older Chinese adults in primary care settings: Prevalence and correlates.Frontiers in public health · 2022Article
- A study on the anxiety level and stress during Covid19 lockdown among the general population of West Bengal, India- A must know for primary care physicians.Journal of family medicine and primary care · 2021Article
- The reliability, validity and factorial structure of the Swahili version of the 7-item generalized anxiety disorder scale (GAD-7) among adults living with HIV from Kilifi, Kenya.Annals of general psychiatry · 2020Article
- [Cumulative incidence, comorbility and disability for anxiety disorders in patients of a mutual worker accident.]Revista espanola de salud publica · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeGeneralized Anxiety Disorder (GAD) is a common mental disorder in the primary care setting, marked by persistent anxiety and worries. The aims of this study were to: 1) examine mental health services utilisation in a large sample of primary care patients; 2) explore detection of GAD and minimal standards for pharmacological and psychological treatment adequacy based on recommendation from clinical practice guidelines; 3) examine correlates of treatment adequacy, i.e. predisposing, enabling and needs factors according to the Behavioural Model of Health Care Use.
methodsA sample of 373 adults meeting DSM-IV criteria for Generalized Anxiety Disorder in the past 12 months took part in this study. Data were drawn from the "Dialogue" project, a large primary care study conducted in 67 primary care clinics in Quebec, Canada. Following a mental health screening in medical clinics (n = 14833), patients at risk of anxiety or depression completed the Composite International Diagnostic Interview-Simplified (CIDIS). Multilevel logistic regression models were developed to examine correlates of treatment adequacy for pharmacological and psychological treatments.
resultsResults indicate that 52.5 % of participants were recognized as having GAD by a healthcare professional in the past 12 months, and 36.2 % of the sample received a pharmacological (24.4 %) and/or psychological treatment (19.2 %) meeting indicators based on clinical practice guidelines recommendations. The detection of GAD by a health professional and the presence of comorbid depression were associated with overall treatment adequacy.
conclusionsThis study suggests that further efforts towards GAD detection could lead to an increase in the delivery of evidence-based treatments. Key targets for improvement in treatment adequacy include regular follow up of patients with a GAD medication and access to psychotherapy from the primary care setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.